LeafNLP Demos
Back to explore

Report #2888209

Received Mar 9, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
PA
Recovered
Unknown
Vaccinated
Mar 5, 2026
Onset
Mar 5, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
HPV9HPV (GARDASIL 9)MERCK & CO. INC.3Z005055—

Symptoms (2)

Expired product administeredNo adverse event

Symptom narrative

No other AE; patient being administered an expired dose of GARDASIL 9 as her 3rd dose in a 3-dose regimen; This spontaneous report was received from a registered nurse (R. N.)concerning a 32-year-old female patient. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. Her historical drugs included the first and second doses of HPV vaccine VLP rL1 9v (yeast) (GARDASIL 9.) On 05-Mar-2026, the patient was administered an expired dose of Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9) suspension for injection, 0.5 mL, batch/lot number Z005055, expiration date 27-Feb-2026, as her third dose in a 3-dose regimen for prophylaxis (expired product administered) (anatomical location and route of administration were not reported.) There were no other adverse events (AE) (no adverse event.)